Preoperative Sildenafil administration in children undergoing cardiac surgery

a randomized controlled preconditioning study

Varsha Walavalkar, Egmond Evers, Suresh Pujar, Kiran Viralam, Shreesha Maiya, Stefan Frerich, Colin John, Shekhar Rao, Chinnaswamy Reddy, Bart Spronck, FritsW. Prinzen, Tammo Delhaas, Ward Y. Vanagt*

*Corresponding author for this work

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

OBJECTIVES: Sildenafil has strong cardiac preconditioning properties in animal studies and has a safe side-effect profile in children. Therefore, we evaluated the application of Sildenafil preconditioning to reduce myocardial ischaemia/reperfusion injury in children undergoing surgical ventricular septal defect (VSD) closure.

METHODS: This is a randomized, double-blind study. Children (1-17 years) undergoing VSD closure were randomized into three groups: placebo (Control group), preconditioning with 0.06 mg/kg (Sild-L group) and 0.6 mg/kg Sildenafil (Sild-H group). Primary endpoint: troponin release. CK-MB, Troponin I, inflammatory response (IL-6 and TNF-α), bypass and ventilation weaning times, inotropy score and echocardiographic function were assessed. Data expressed as median (range), and a value of P <0.05 was considered significant.

RESULTS: Thirty-nine patients were studied (13/group). Aortic cross-clamp time was similar [27 (18-85) and 27 (12-39) min] in the Control and Sild-L groups, respectively, but significantly longer [39 (20-96) min] in the Sild-H group when compared with the Control group. Area under the curve of CK-MB release was 1105 (620-1855) h ng/ml in the Control group, 1672 (564-2767) h ng/ml in the SildL group and was significantly higher in the Sild-H group [1695 (1252-3377) h ng/ml] when compared with the Control group. There were no significant differences in inflammatory response markers, cardiopulmonary bypass and ventilation weaning times, inotropy scores and echocardiographic function between the groups.

CONCLUSIONS: In this small study, Sildenafil failed to reduce myocardial injury in children undergoing cardiac surgery, nor does it alter cardiac function, inotropic needs or postoperative course. A subclinical increase in cardiac enzyme release after Sildenafil preconditioning cannot be excluded.

Original languageEnglish
Pages (from-to)1403-1410
Number of pages8
JournalEuropean Journal of Cardio-thoracic Surgery
Volume49
Issue number5
DOIs
Publication statusPublished - May 2016
Externally publishedYes

Keywords

  • congenital heart disease
  • preconditioning
  • cardioprotection
  • cardiac surgery

Cite this